Section of Vascular and Endovascular Surgery, Boston University Medical Center, Boston, MA 02119-2393, USA.
Semin Vasc Surg. 2011 Jun;24(2):63-71. doi: 10.1053/j.semvascsurg.2011.05.004.
The emphasis on autogenous arteriovenous hemodialysis access has increased the focus on the brachial-basilic autogenous configuration currently recommended by the national guidelines when the cephalic vein is not suitable. The brachial-basilic autogenous access has been extensively studied and compared with both prosthetic (arteriovenous graft [AVG]) and other autogenous accesses. The literature suggests that the brachial-basilic autogenous access is superior to AVGs in terms of patency, reintervention rates, and infectious complications. However, controversy still remains with respect to its role in the treatment algorithm and the technical conduct of the operation. This review will address the ongoing issues and controversies surrounding the brachial-basilic autogenous access and define its role for the hemodialysis access surgeon.
强调自体动静脉血液透析通路，增加了对当前国家指南推荐的当头静脉不适用时的肱动脉-贵要静脉自体构型的关注。肱动脉-贵要静脉自体通路已经得到广泛研究，并与人工（动静脉移植物[AVG]）和其他自体通路进行了比较。文献表明，在通畅性、再干预率和感染并发症方面，肱动脉-贵要静脉自体通路优于 AVG。然而，其在治疗算法和手术技术操作中的作用仍存在争议。本综述将讨论围绕肱动脉-贵要静脉自体通路的持续问题和争议，并为血液透析通路外科医生确定其作用。
